Atea Pharmaceuticals, Inc.
Overview
Atea Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antiviral therapies to address significant unmet medical needs. The company's lead product candidate is AT-527, an orally administered, direct-acting antiviral in clinical trials for the treatment of COVID-19.
Therapeutic areas
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Atea Pharmaceuticals, Inc. in our records. PharmaTek screens the full directory against live FDA enforcement data.
Is this Atea Pharmaceuticals, Inc.? Get in front of buyers actively sourcing.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Related companies
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.